2004, Number 4
<< Back Next >>
Perinatol Reprod Hum 2004; 18 (4)
Infección cervical por virus del papiloma humano: genotipificación por hibridación in situ y análisis ultraestructural por microscopia electrónica de transmisión
Barrón A, Aranda C, Valenzuela S, Paredes Y, Villegas H
Language: Spanish
References: 25
Page: 208-216
PDF size: 436.18 Kb.
ABSTRACT
Introduction: Human papillomavirus (HPV) is the most common sexually transmitted virus, is strongly associated with cervical cancer. HPV genital types differs in oncogenic potential, types 6/11 are low-risk and, types 16/18, 31/33 are high-risk. In situ Hybridization (ISH) analysis has advantage of being able to detect both, the specific cellular types infected with viral DNA and the HPV types in cervical biopsies and therefore, cervical cancer patients risk.
Objective: This work was performed in order to typing HPV in cervical biopsies with cytological, colposcopical and histopathological evidence of HPV infection, and to search ultrastructural changes associates with viral infection.
Results: We analyzed, by ISH, 63 cervical biopsies, 24 (38%) positives to some viral type, HPV types 6/11 were more common types (24%) consistent with the more frequent, both colposcopical and histopathological diagnostic; Low-grade intraepithelial lesion. Ultraestructural analysis showed cellular alteration in association with low-risk types, principally irregular nucleus and several nucleolus for nucleus, as long as cells infected with oncogenic types DNA showed multilobulated nucleus, cytoplasmic inclusions and viral particles in nucleus. In both cases is clear an disorganization of cellular junctions desmosomes.
Conclusions: The HPV prevalence in this study was consistent with other reported, using ISH analysis, the more common types were low-risk types in agreement with previous diagnostic, and electron microscopy analysis provide evidence on the main cell alterations associated with viral infection.
REFERENCES
Burd E. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003; 16: 1-17.
Koutski L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102: 3-8.
Cates W. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. The American Social Health Association Panel. Sex Transm Dis 1999; 26: S2-S7.
Zur Hausen H. Papillomavirus infection ―a major cause of human cancers―. Biochem Biophys Acta 1996; 1288: F55-78.
Kisseljov FL. Virus-associated human tumors: carcinomas and papillomaviruses. Biochemistry 2000; 65: 68-77.
Einstein M, Goldberg G. Human papillomavirus and cervical neoplasia. Cancer Invest 2002; 20: 1080-5.
Muñoz N, Bosch J, Sanjosé S, Herrero R, Castellsange X, Shah K, Snijders P, Meijer C. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Eng J Med 2003; 348: 518-27.
Franco E. Cancer causes revisited: human papillomavirus and cervical neoplasia. J Natn Cancer Inst 1995; 87: 779-80
International Agency for Research on Cancer 2001. Disponible en www.iarc.fr
Walboomers M, Meijer J. Do HPV-negative cervical carcinomas exist? J Pathol 1999; 181: 253-4.
Andersson S, Rylander E, Larsson B, Strand A, Silfvervard C, Wilander E. The role of human papillomavirus in cervical adenocarcinomas carcinogenesis. Eur J Cancer 2001; 37:246-50.
Breutner K, Tyring S. Human papillomavirus and human disease. Am J Med 1997;102: 9-15.
Kurman R, Henson D, Herbst A, Noeller K, Schiffman M. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Workshop. JAMA 1994; 271: 1866-9.
Salomon D, Davey D, Kurman R, Morierty A, O´Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-9.
Tamayo E, Echaniz G, Cruz A, Camacho G, Calderón E. Infección por el virus del papiloma humano en mujeres con y sin citología anormal. Ginec Obstet Mex 1993; 61: 27-34.
Hernández M, Lazcano C, Beruman J, Cruz A, Alonso P, González G. Human papilloma virus 16-18 infection and cervical cancer in Mexico: A case-control study. Arch Med Res 1997; 28: 265-71.
Sato S, Maruta J, Ito K, Konno R, Yajima A, Sasaki H. Prognostic features of cervical dysplasia associated with specific types of HPV DNA and cytologic features characteristic of HPV infection in dysplasia. Acta Cytol 1998; 42: 1377-81.
Brown D, Legge D, Qadadri B. Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic. Sex Transm Dis 2002; 29: 763-8.
Coutlee F, Gravitt P, Kornegay J, Hankis K, Richardson H, Lapointe N, Voyer H, the Canadian women´s HIV study group, Franco E. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus in genital samples. J Clin Microbiol 2002; 40: 902-7.
Wilczinski S, Bergen S, Walker J, Liao S, Pearlman L. Human papillomavirus and cervical cancer. Hum Pathol 1988; 19: 697-704.
Zamora A, Terrés M. Infección por virus del papiloma humano en mujeres y hombres mexicanos. Identificación por el sistema de captura de híbridos. Rev Mex Patol Clin 1998; 45: 9-16.
Crum C, Berkowitz R. Human papillomavirus; Applications, caveats and prevention. J Reprod Med 2002; 47: 519-28.
An H, Lee S, Kim I, Lee C, Kim S, Mun M, Kim S, Jeong J. Correlation of cervical carcinomas and precancerous lesion with human papillomavirus (HPV) phenotypes detected with the HPV DNA chip microarray method. Cancer 2003; 97: 1672-80.
Kim C, Jeong J, Park M, Park T, Park T, Namkoong S, Park J. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol 2003; 89: 210-7.
Sato S, Okagaki T, Clark B, Twiggs L, Fukushima M, Ostrow R, Faras A. Sensitivity of koilocytosis, immunocytochemistry, and electron microscopy as compared to DNA hibridization in detecting human papillomavirus in cervical and vaginal condyloma and intraepithelial neoplasia. Int J Gynecol Pathol 1987; 5: 297-307.
Full text